252 related articles for article (PubMed ID: 1317488)
21. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias.
Burger H; Nooter K; Zaman GJ; Sonneveld P; van Wingerden KE; Oostrum RG; Stoter G
Leukemia; 1994 Jun; 8(6):990-7. PubMed ID: 7911548
[TBL] [Abstract][Full Text] [Related]
22. The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells.
Brieger J; Weidmann E; Fenchel K; Mitrou PS; Hoelzer D; Bergmann L
Leukemia; 1994 Dec; 8(12):2138-43. PubMed ID: 7808002
[TBL] [Abstract][Full Text] [Related]
23. c-fms expression in acute leukemias with complex phenotypes.
Torrès H; Dubreuil P; Falzetti F; Courcoul MA; Lopez M; Falcinelli F; Birg F; Tabilio A; Mannoni P
Leukemia; 1990 Oct; 4(10):673-7. PubMed ID: 2214871
[TBL] [Abstract][Full Text] [Related]
24. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
[TBL] [Abstract][Full Text] [Related]
25. Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis.
Galimberti S; Guerrini F; Carulli G; Fazzi R; Palumbo GA; Morabito F; Petrini M
Eur J Haematol; 2004 Jan; 72(1):45-51. PubMed ID: 14962262
[TBL] [Abstract][Full Text] [Related]
26. [Expression of WT1 gene in leukemia and its significance].
Wu X; Wang Y; Pei X
Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):46-8. PubMed ID: 10921100
[No Abstract] [Full Text] [Related]
27. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants.
Siehl JM; Reinwald M; Heufelder K; Menssen HD; Keilholz U; Thiel E
Ann Hematol; 2004 Dec; 83(12):745-50. PubMed ID: 15340762
[TBL] [Abstract][Full Text] [Related]
28. Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias: relationship to the expression of cell cycle-related genes.
Ferrari S; Tagliafico E; Ceccherelli G; Selleri L; Calabretta B; Donelli A; Temperani P; Sarti M; Sacchi S; Emilia G
Leukemia; 1989 Jun; 3(6):423-30. PubMed ID: 2542700
[TBL] [Abstract][Full Text] [Related]
29. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia.
Barragán E; Cervera J; Bolufer P; Ballester S; Martín G; Fernández P; Collado R; Sayas MJ; Sanz MA
Haematologica; 2004 Aug; 89(8):926-33. PubMed ID: 15339675
[TBL] [Abstract][Full Text] [Related]
30. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
[TBL] [Abstract][Full Text] [Related]
31. High expression of two diverged homeobox genes, HB24 and HB9, in acute leukemias: molecular markers of hematopoietic cell immaturity.
Deguchi Y; Yamanaka Y; Theodossiou C; Najfeld V; Kehrl JH
Leukemia; 1993 Mar; 7(3):446-51. PubMed ID: 7680402
[TBL] [Abstract][Full Text] [Related]
32. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
[TBL] [Abstract][Full Text] [Related]
33. Real-time PCR quantification of major Wilms' tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences.
Kramarzova K; Stuchly J; Willasch A; Gruhn B; Schwarz J; Cermak J; Machova-Polakova K; Fuchs O; Stary J; Trka J; Boublikova L
Leukemia; 2012 Sep; 26(9):2086-95. PubMed ID: 22430637
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
[TBL] [Abstract][Full Text] [Related]
35. Wilms' tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action?
Olszewski M; Huang W; Chou PM; Duerst R; Kletzel M
Cytotherapy; 2005; 7(1):57-61. PubMed ID: 16040384
[TBL] [Abstract][Full Text] [Related]
36. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
Algar EM; Kenney MT; Simms LA; Smith SI; Kida Y; Smith PJ
Hum Mutat; 1995; 5(3):221-7. PubMed ID: 7599632
[TBL] [Abstract][Full Text] [Related]
37. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
[TBL] [Abstract][Full Text] [Related]
38. [The Wilms' tumor suppressor gene WT1].
Akiyama T
Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1612-7. PubMed ID: 9279088
[No Abstract] [Full Text] [Related]
39. WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies.
Rosenfeld C; Cheever MA; Gaiger A
Leukemia; 2003 Jul; 17(7):1301-12. PubMed ID: 12835718
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneous expression of the product of the retinoblastoma susceptibility gene in primary human leukemia cells.
Furukawa Y; DeCaprio JA; Belvin M; Griffin JD
Oncogene; 1991 Aug; 6(8):1343-6. PubMed ID: 1886710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
